secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2022-03-16T23:59:59+00:00
Accession:  0001193805-22-000504
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic appoints Glenn Whaley as CFO and extends Executive Chairman Duane Nash's term to Dec 2022
--------------------------------------------------------------------------------

- Glenn Whaley appointed CFO effective March 10, 2022; received option grant for 40,000 shares (25% vest March 10, 2023, remainder monthly).
- Duane Nash's Executive Chairman agreement extended to December 31, 2022; base salary $29,358/month.
- Nash receives one-time option grant for 75,000 shares, vesting monthly from April 10, 2022.
- Both option exercise prices set at closing price on board approval date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380522000504/0001193805-22-000504-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380522000504/e621458_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-22-000504

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer